FindTrial
Sign In

Role of Rasnadi Tail Matrabasti In kashtartava

A Single Arm Open Label Clinical Study to Evaluate the Efficacy of Rasnadi Tail Matrabasti In kashtartava - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075364
Enrollment
60
Registered
2024-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea Health Condition 2: N945- Secondary dysmenorrhea

Interventions

None listed

Sponsors

Dr Priyanka Siddharth Ladhe
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having regular and Irregular menstrual cycle. Age between 18-40 years of female patients. Patients complaining painful menstruation for atleast 3 consecutive cycles.

Exclusion criteria

Exclusion criteria: History of Malignancy. Excessive Bleeding, Mennorrhagia. K/C/O Bicornute uterus, sepated uterus, fibroid uterus. Other Reproductive tract Pathology. Pregnant ladies.

Design outcomes

Primary

MeasureTime frame
To determine the efficacy of Rasnadi tail Matra basti in kashtartava.Timepoint: Assessment of the efficacy of Rasnadi tail Matra basti In kashtartava for 3 consecutive menstrual cycle.—

Secondary

MeasureTime frame
To determine the efficacy of Rasnadi tail Matra basti in kashtartava.Timepoint: Assessment of Rasnadi tail Matra basti in kashtartava for 4 weeks.—

Countries

India

Contacts

Public ContactDr Priyanka Siddharth Ladhe

Ashtang Ayurved Mahavidyalaya Sadaashiv Peth, Pune 411030

hrj9371@gmail.com9881466344

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026